• No results found

18 results with keyword: 'intravitreal bevacizumab avastin diabetic retinopathy gladaof lecture'

Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: the 2010 GLADAOF Lecture

Risk Factors for the Development or Progression of Tractional Retinal Detachment following Intravitreal Bevacizumab (Avastin) in Patients with Severe Proliferative

Protected

N/A

14
0
0
2021
Intravitreal Avastin (Bevacizumab)

E09.3211 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema right eye. E09.3212 Drug or chemical induced diabetes

Protected

N/A

5
0
0
2022
A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema

Net: Diabetic Retinopathy Clinical Research Network; ETDRS: Early Treatment Diabetic Retinopathy Study; FDA: Food & Drug Administration; IVB: Intravitreal bevacizumab;

Protected

N/A

11
0
0
2020
Avastin (Bevacizumab) Intravitreal Injection

Research has shown that VEGF is one of the causes for the growth of the abnormal vessels in AMD and leaking of retinal blood vessels in macular edema.. Once approved by the

Protected

N/A

5
0
0
2021
List Approved Titile Dissertation 1011 Medical 090811

Comparison of single dose intravitreal bevacizumab versus single dose intravitreal triamcinolone acetonide in the treatment of cystoid macular edema due to diabetic retinopathy

Protected

N/A

53
0
0
2021
Effect of bevacizumab, which remain after withdrawal of the first dose/s from a single-use vial on diabetic macular edema

Intravitreal bevacizumab (Avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Sakata K, Funatsu

Protected

N/A

5
0
0
2020
Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy

Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group

Protected

N/A

5
0
0
2021
BOMGAR FOR VENDOR ACCESS SECURE REMOTE ACCESS FOR THIRD-PARTIES

For internal IT organisations, Bomgar’s Embassy technology is a way to provide secure, auditable, cross-platform remote access to vendors who need to regularly access

Protected

N/A

5
0
0
2021
Optimal Allocation of Filters against DDoS Attacks

We vary the number of attackers (from 1000 to 50000) and we allocate filters to individual attackers (attackers’ one- tier problem ) 3. In Fig6, optimal filtering clearly

Protected

N/A

10
0
0
2021
U 2 -Net: Going Deeper with Nested U-Structure for Salient Object Detection

This is achieved by a nested U-structure: on the bottom level, we design a novel ReSidual U-block (RSU), which is able to extract intra-stage multi-scale fea- tures without

Protected

N/A

15
0
0
2021
Visual Outcome of Intravitreal Bevacizumab in Treatment of Diabetic Retinopathy

due to which exact role of bevacizumab, regarding visual outcome, cannot be assessed .Patients with other associated posterior segment diseases affecting the

Protected

N/A

5
0
0
2021
The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy

Background: This study evaluated the effect of intravitreal injection of bevacizumab (IVB) on macular edema associated with diabetic retinopathy (DME) or branch retinal vein

Protected

N/A

9
0
0
2020
Discrete Space Vector Modulation Algorithm Based Vector Controlled Induction Motor  Drive

From the steady state simulation results and harmonic spectra of line currents, it can be concluded that the proposed DSVM based vector control algorithm gives

Protected

N/A

7
0
0
2020
Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy

Purpose: To report the 24-month anatomic and Early Treatment Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA) response after primary intravitreal

Protected

N/A

147
0
0
2021
Effect of intravitreal aflibercept on recalcitrant diabetic macular edema

DME: diabetic macular edema; IVB: intravitreal bevacizumab; IVR: intravitreal ranibizumab; IAI: intravitreal aflibercept injection; IVTA: intravitreal triam- cinolone acetonide;

Protected

N/A

7
0
0
2020
The efficacy and safety of aflibercept and conbercept in diabetic macular edema

Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-

Protected

N/A

13
0
0
2020
VOLUME- 3 ISSUE- 12 DECEMBER Regulation Of Lifestyle Diseases Through Yoga Practice

The holistic art and science of yoga is the best lifestyle ever designed and effective, yoga provides great option for the preventions and management for lifestyle

Protected

N/A

9
0
0
2021
Vibrios: Symbiotic Relationships and Human Health. Michele Copello Osceola Fundamental High School. Abstract:

Advance Preparation:  Order the Vibrio fisheri a minimum of 3 weeks in advance to arrive the time you 

Protected

N/A

8
0
0
2021

Upload more documents and download any material studies right away!